| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.307 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| APC |
IPI00215877 |
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
1.307 |
Evidence |
|
| APC |
IPI00215877 |
CDH5 |
CDH5: Cadherin-5 precursor |
1.307 |
Evidence |
|
| APC |
IPI00215877 |
DSG3 |
DSG3: Desmoglein-3 precursor |
1.307 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
IFI35 |
IPI00218475 |
1.307 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.307 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
1.307 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.307 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.307 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CHUK |
IPI00556043 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
ABCF1 |
IPI00013495 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CRIP2 |
CRIP2, CRP2: Cysteine-rich protein 2 |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
1.307 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
1.307 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
1.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
1.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
1.307 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.307 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
1.307 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
KRT18 |
KRT18: Uncharacterized protein KRT18 |
1.307 |
Evidence |
|
| SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
1.307 |
Evidence |
|